The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1

Authors: Andrew A. Wylie, Joseph Schoepfer, Wolfgang Jahnke, Sandra W. Cowan‐Jacob, Alice Loo, Pascal Furet, Andreas L. Marzinzik, Xavier Pellé, Jerry Donovan, Wenjing Zhu, Silvia Buonamici, Amr Hassan, Franco Lombardo, Varsha Iyer, Michael R. Palmer, Giuliano Berellini, Stephanie Dodd, Sanjeev Thohan, Hans Bitter, Susan Branford, David M. Ross, Timothy P. Hughes, Lilli Petruzzelli, K. Gary J. Vanasse, Markus Warmuth, Francesco Hofmann, Nicholas Keen, William R. Sellers - Nature 2017 cited by 614